Safety and Efficacy of Apixaban in Very Old Geriatric Subjects (> 80 Years) With Atrial FIbrillation in a Prospective reAl World Study;
NCT04586972
·
clinicaltrials.gov ↗
COMPLETED
Status
977
Enrollment
OTHER
Sponsor class
Conditions
Nonvalvular Atrial Fibrillation
Sponsor
Gérond'if